# MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children

> **NCT05541276** · PHASE3 · RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 400 (estimated)

## Conditions studied

- Emergence Delirium

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Isotonic sodium chloride solution

## Key facts

- **NCT ID:** NCT05541276
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-01-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05541276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05541276, "MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05541276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*